Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Cardiotoxicity of Immune Checkpoint Inhibitors.

Zhang L, Jones-O'Connor M, Awadalla M, Zlotoff DA, Thavendiranathan P, Groarke JD, Villani AC, Lyon AR, Neilan TG.

Curr Treat Options Cardiovasc Med. 2019 Jun 8;21(7):32. doi: 10.1007/s11936-019-0731-6. Review.

PMID:
31175469
2.

Adapting a Compilation of Implementation Strategies to Advance School-Based Implementation Research and Practice.

Cook CR, Lyon AR, Locke J, Waltz T, Powell BJ.

Prev Sci. 2019 May 31. doi: 10.1007/s11121-019-01017-1. [Epub ahead of print]

PMID:
31152328
3.

The influence of a blended, theoretically-informed pre-implementation strategy on school-based clinician implementation of an evidence-based trauma intervention.

Lyon AR, Cook CR, Duong MT, Nicodimos S, Pullmann MD, Brewer SK, Gaias LM, Cox S.

Implement Sci. 2019 May 30;14(1):54. doi: 10.1186/s13012-019-0905-3.

4.

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.

Seferović PM, Polovina M, Bauersachs J, Arad M, Gal TB, Lund LH, Felix SB, Arbustini E, Caforio ALP, Farmakis D, Filippatos GS, Gialafos E, Kanjuh V, Krljanac G, Limongelli G, Linhart A, Lyon AR, Maksimović R, Miličić D, Milinković I, Noutsias M, Oto A, Oto Ö, Pavlović SU, Piepoli MF, Ristić AD, Rosano GMC, Seggewiss H, Ašanin M, Seferović JP, Ruschitzka F, Čelutkiene J, Jaarsma T, Mueller C, Moura B, Hill L, Volterrani M, Lopatin Y, Metra M, Backs J, Mullens W, Chioncel O, de Boer RA, Anker S, Rapezzi C, Coats AJS, Tschöpe C.

Eur J Heart Fail. 2019 May;21(5):553-576. doi: 10.1002/ejhf.1461. Epub 2019 Apr 16.

PMID:
30989768
5.

Genetic Variants Associated with Cancer Therapy-Induced Cardiomyopathy.

Garcia-Pavia P, Kim Y, Alejandra Restrepo-Cordoba M, Lunde IG, Wakimoto H, Smith AM, Toepfer CN, Getz K, Gorham J, Patel P, Ito K, Willcox JA, Arany Z, Li J, Owens AT, Govind R, Nuñez B, Mazaika E, Bayes-Genis A, Walsh R, Finkelman B, Lupon J, Whiffin N, Serrano I, Midwinter W, Wilk A, Bardaji A, Ingold N, Buchan R, Tayal U, Pascual-Figal DA, de Marvao A, Ahmad M, Garcia-Pinilla JM, Pantazis A, Dominguez F, Baksi AJ, O'Regan DP, Rosen SD, Prasad SK, Lara-Pezzi E, Provencio M, Lyon AR, Alonso-Pulpon L, Cook SA, DePalma SR, Barton PJR, Aplenc R, Seidman JG, Ky B, Ware JS, Seidman CE.

Circulation. 2019 Apr 16. doi: 10.1161/CIRCULATIONAHA.118.037934. [Epub ahead of print]

PMID:
30987448
6.

The continuous heart failure spectrum: moving beyond an ejection fraction classification.

Triposkiadis F, Butler J, Abboud FM, Armstrong PW, Adamopoulos S, Atherton JJ, Backs J, Bauersachs J, Burkhoff D, Bonow RO, Chopra VK, de Boer RA, de Windt L, Hamdani N, Hasenfuss G, Heymans S, Hulot JS, Konstam M, Lee RT, Linke WA, Lunde IG, Lyon AR, Maack C, Mann DL, Mebazaa A, Mentz RJ, Nihoyannopoulos P, Papp Z, Parissis J, Pedrazzini T, Rosano G, Rouleau J, Seferovic PM, Shah AM, Starling RC, Tocchetti CG, Trochu JN, Thum T, Zannad F, Brutsaert DL, Segers VF, De Keulenaer GW.

Eur Heart J. 2019 Apr 8. pii: ehz158. doi: 10.1093/eurheartj/ehz158. [Epub ahead of print]

PMID:
30957868
7.

Anticoagulation of Cardiovascular Conditions in the Cancer Patient: Review of Old and New Therapies.

Rhea IB, Lyon AR, Fradley MG.

Curr Oncol Rep. 2019 Apr 4;21(5):45. doi: 10.1007/s11912-019-0797-z. Review.

PMID:
30949848
8.

Mind the Gap: Considering Disparities in Implementing Measurement-Based Care.

Liu FF, Cruz RA, Rockhill CM, Lyon AR.

J Am Acad Child Adolesc Psychiatry. 2019 Apr;58(4):459-461. doi: 10.1016/j.jaac.2018.11.015.

PMID:
30926072
9.

Leadership profiles associated with the implementation of behavioral health evidence-based practices for autism spectrum disorder in schools.

Stadnick NA, Meza RD, Suhrheinrich J, Aarons GA, Brookman-Frazee L, Lyon AR, Mandell DS, Locke J.

Autism. 2019 Mar 27:1362361319834398. doi: 10.1177/1362361319834398. [Epub ahead of print]

PMID:
30915854
10.

Individual and organizational factors that affect implementation of evidence-based practices for children with autism in public schools: a cross-sectional observational study.

Locke J, Lawson GM, Beidas RS, Aarons GA, Xie M, Lyon AR, Stahmer A, Seidman M, Frederick L, Oh C, Spaulding C, Dorsey S, Mandell DS.

Implement Sci. 2019 Mar 13;14(1):29. doi: 10.1186/s13012-019-0877-3.

11.

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors.

Awadalla M, Golden DLA, Mahmood SS, Alvi RM, Mercaldo ND, Hassan MZO, Banerji D, Rokicki A, Mulligan C, Murphy SPT, Jones-O'Connor M, Cohen JV, Heinzerling LM, Armanious M, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Rizvi MA, Sahni G, Lyon AR, Tocchetti CG, Mercurio V, Thuny F, Ederhy S, Mahmoudi M, Lawrence DP, Groarke JD, Nohria A, Fradley MG, Reynolds KL, Neilan TG.

J Immunother Cancer. 2019 Feb 22;7(1):53. doi: 10.1186/s40425-019-0535-y.

12.

Late onset heart failure after childhood chemotherapy.

Hilfiker-Kleiner D, Ardehali H, Fischmeister R, Burridge P, Hirsch E, Lyon AR.

Eur Heart J. 2019 Mar 7;40(10):798-800. doi: 10.1093/eurheartj/ehz046. No abstract available.

PMID:
30753420
13.

Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced age.

Lugtenburg PJ, Lyon AR, Marks R, Luminari S.

Future Oncol. 2019 Apr;15(11):1197-1205. doi: 10.2217/fon-2019-0019. Epub 2019 Feb 7.

14.

Cardiovascular toxicities associated with immune checkpoint inhibitors.

Hu JR, Florido R, Lipson EJ, Naidoo J, Ardehali R, Tocchetti CG, Lyon AR, Padera RF, Johnson DB, Moslehi J.

Cardiovasc Res. 2019 Apr 15;115(5):854-868. doi: 10.1093/cvr/cvz026. Erratum in: Cardiovasc Res. 2019 Apr 15;115(5):868.

PMID:
30715219
15.

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.

de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, Du XJ, Ford P, Heinzel FR, Lipson KE, McDonagh T, Lopez-Andres N, Lunde IG, Lyon AR, Pollesello P, Prasad SK, Tocchetti CG, Mayr M, Sluijter JPG, Thum T, Tschöpe C, Zannad F, Zimmermann WH, Ruschitzka F, Filippatos G, Lindsey ML, Maack C, Heymans S.

Eur J Heart Fail. 2019 Mar;21(3):272-285. doi: 10.1002/ejhf.1406. Epub 2019 Feb 4.

16.

Testing and Exploring the Limits of Traditional Notions of Fidelity and Adaptation in Implementation of Preventive Interventions.

Lewis CC, Lyon AR, McBain SA, Landes SJ.

J Prim Prev. 2019 Feb;40(1):137-141. doi: 10.1007/s10935-019-00539-2.

PMID:
30684091
17.

Measuring the Implementation of Behavioral Intervention Technologies: Recharacterization of Established Outcomes.

Hermes ED, Lyon AR, Schueller SM, Glass JE.

J Med Internet Res. 2019 Jan 25;21(1):e11752. doi: 10.2196/11752.

18.

Is P2Y12 inhibitor therapy associated with an increased risk of cancer?

Kaufmann CC, Lyon AR, Wojta J, Huber K.

Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):100-104. doi: 10.1093/ehjcvp/pvz003. Review.

PMID:
30657876
19.

Integrating implementation and user-centred design strategies to enhance the impact of health services: protocol from a concept mapping study.

Dopp AR, Parisi KE, Munson SA, Lyon AR.

Health Res Policy Syst. 2019 Jan 8;17(1):1. doi: 10.1186/s12961-018-0403-0.

20.

Break a sweat to reduce cardiotoxicity - the benefits of exercise training during anthracycline chemotherapy.

Lyon AR, Habibian M.

Eur J Prev Cardiol. 2019 Feb;26(3):301-304. doi: 10.1177/2047487318821239. Epub 2019 Jan 7. No abstract available.

21.

Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'.

Anker MS, Lena A, Hadzibegovic S, Belenkov Y, Bergler-Klein J, de Boer RA, Cohen-Solal A, Farmakis D, von Haehling S, López-Fernández T, Pudil R, Suter T, Tocchetti CG, Lyon AR; Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology.

ESC Heart Fail. 2018 Dec;5(6):1083-1091. doi: 10.1002/ehf2.12386. Review.

22.

A glossary of user-centered design strategies for implementation experts.

Dopp AR, Parisi KE, Munson SA, Lyon AR.

Transl Behav Med. 2018 Dec 7. doi: 10.1093/tbm/iby119. [Epub ahead of print]

PMID:
30535343
23.

Chronic intake of 4-Methylimidazole induces Hyperinsulinemia and Hypoglycaemia via Pancreatic Beta Cell Hyperplasia and Glucose Dyshomeostasis.

Rekha B, Velmurugan G, Freddy AJ, Anusha S, Ramprasath T, Karthik KV, Suresh S, Kulshrestha P, Mithieux G, Lyon AR, Selvam GS, Ramasamy S.

Sci Rep. 2018 Nov 19;8(1):17037. doi: 10.1038/s41598-018-35071-6.

24.

User-Centered Redesign of Evidence-Based Psychosocial Interventions to Enhance Implementation-Hospitable Soil or Better Seeds?

Lyon AR, Bruns EJ.

JAMA Psychiatry. 2018 Nov 14. doi: 10.1001/jamapsychiatry.2018.3060. [Epub ahead of print] No abstract available.

PMID:
30427985
25.

Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink.

Chidwick K, Strongman H, Matthews A, Stanway S, Lyon AR, Smeeth L, Bhaskaran K.

BMC Cancer. 2018 Oct 22;18(1):1018. doi: 10.1186/s12885-018-4947-8.

26.

[Fourth universal definition of myocardial infarction (2018)].

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL Jr, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM Jr, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O'Gara PT, Fox KAA.

Kardiol Pol. 2018;76(10):1383-1415. doi: 10.5603/KP.2018.0203. Polish. No abstract available.

27.

Characterization of NAD(P)H and FAD autofluorescence signatures in a Langendorff isolated-perfused rat heart model.

Lagarto JL, Dyer BT, Talbot CB, Peters NS, French PMW, Lyon AR, Dunsby C.

Biomed Opt Express. 2018 Sep 21;9(10):4961-4978. doi: 10.1364/BOE.9.004961. eCollection 2018 Oct 1.

28.

Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review.

Matthews A, Stanway S, Farmer RE, Strongman H, Thomas S, Lyon AR, Smeeth L, Bhaskaran K.

BMJ. 2018 Oct 8;363:k3845. doi: 10.1136/bmj.k3845.

29.

Treatments targeting inotropy.

Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristic A, Ruschitzka F, Seferovic PM, Skouri H, Zimmermann WH, Mebazaa A.

Eur Heart J. 2018 Oct 8. doi: 10.1093/eurheartj/ehy600. [Epub ahead of print]

PMID:
30295807
30.

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.

Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J, Bayes-Genis A, Brutsaert D, Bugger H, Clarke K, Cosentino F, De Keulenaer G, Dei Cas A, González A, Huelsmann M, Iaccarino G, Lunde IG, Lyon AR, Pollesello P, Rena G, Riksen NP, Rosano G, Staels B, van Laake LW, Wanner C, Farmakis D, Filippatos G, Ruschitzka F, Seferovic P, de Boer RA, Heymans S.

Eur Heart J. 2018 Dec 21;39(48):4243-4254. doi: 10.1093/eurheartj/ehy596. No abstract available.

31.

Immune checkpoint inhibitors and cardiovascular toxicity.

Lyon AR, Yousaf N, Battisti NML, Moslehi J, Larkin J.

Lancet Oncol. 2018 Sep;19(9):e447-e458. doi: 10.1016/S1470-2045(18)30457-1. Review.

32.

Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience.

Pareek N, Cevallos J, Moliner P, Shah M, Tan LL, Chambers V, Baksi AJ, Khattar RS, Sharma R, Rosen SD, Lyon AR.

Eur J Heart Fail. 2018 Dec;20(12):1721-1731. doi: 10.1002/ejhf.1292. Epub 2018 Sep 6.

PMID:
30191649
33.

Confirmatory factor analysis of the Evidence-Based Practice Attitudes Scale with school-based behavioral health consultants.

Cook CR, Davis C, Brown EC, Locke J, Ehrhart MG, Aarons GA, Larson M, Lyon AR.

Implement Sci. 2018 Aug 22;13(1):116. doi: 10.1186/s13012-018-0804-z.

34.

Cardio-Oncology Services: rationale, organization, and implementation.

Lancellotti P, Suter TM, López-Fernández T, Galderisi M, Lyon AR, Van der Meer P, Cohen Solal A, Zamorano JL, Jerusalem G, Moonen M, Aboyans V, Bax JJ, Asteggiano R.

Eur Heart J. 2019 Jun 7;40(22):1756-1763. doi: 10.1093/eurheartj/ehy453.

35.

Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials.

Chari A, Stewart AK, Russell SD, Moreau P, Herrmann J, Banchs J, Hajek R, Groarke J, Lyon AR, Batty GN, Ro S, Huang M, Iskander KS, Lenihan D.

Blood Adv. 2018 Jul 10;2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545. Review.

36.

Heart failure resulting from cancer treatment: still serious but an opportunity for prevention.

Lyon AR.

Heart. 2019 Jan;105(1):6-8. doi: 10.1136/heartjnl-2018-313493. Epub 2018 Jul 4. No abstract available.

37.

Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment.

Tan LL, Lyon AR.

Curr Treat Options Cardiovasc Med. 2018 Jun 19;20(7):55. doi: 10.1007/s11936-018-0641-z. Review.

38.

Impact of a Web-Based Electronic Health Record on Behavioral Health Service Delivery for Children and Adolescents: Randomized Controlled Trial.

Bruns EJ, Hook AN, Parker EM, Esposito I, Sather A, Parigoris RM, Lyon AR, Hyde KL.

J Med Internet Res. 2018 Jun 14;20(6):e10197. doi: 10.2196/10197.

39.

From Classification to Causality: Advancing Understanding of Mechanisms of Change in Implementation Science.

Lewis CC, Klasnja P, Powell BJ, Lyon AR, Tuzzio L, Jones S, Walsh-Bailey C, Weiner B.

Front Public Health. 2018 May 7;6:136. doi: 10.3389/fpubh.2018.00136. eCollection 2018.

40.

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.

Eur Heart J. 2018 Jun 7;39(22):2032-2046. doi: 10.1093/eurheartj/ehy076.

41.

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.

Eur Heart J. 2018 Jun 7;39(22):2047-2062. doi: 10.1093/eurheartj/ehy077.

42.

Reliability, Validity, and Factor Structure of the Current Assessment Practice Evaluation-Revised (CAPER) in a National Sample.

Lyon AR, Pullmann MD, Dorsey S, Martin P, Grigore AA, Becker EM, Jensen-Doss A.

J Behav Health Serv Res. 2019 Jan;46(1):43-63. doi: 10.1007/s11414-018-9621-z.

PMID:
29752631
43.

Heart failure with preserved ejection fraction.

Harper AR, Patel HC, Lyon AR.

Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s24-s29. doi: 10.7861/clinmedicine.18-2-s24.

44.

Cardiomyocyte Membrane Structure and cAMP Compartmentation Produce Anatomical Variation in β2AR-cAMP Responsiveness in Murine Hearts.

Wright PT, Bhogal NK, Diakonov I, Pannell LMK, Perera RK, Bork NI, Schobesberger S, Lucarelli C, Faggian G, Alvarez-Laviada A, Zaccolo M, Kamp TJ, Balijepalli RC, Lyon AR, Harding SE, Nikolaev VO, Gorelik J.

Cell Rep. 2018 Apr 10;23(2):459-469. doi: 10.1016/j.celrep.2018.03.053.

45.

Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge.

Ameri P, Canepa M, Anker MS, Belenkov Y, Bergler-Klein J, Cohen-Solal A, Farmakis D, López-Fernández T, Lainscak M, Pudil R, Ruschitska F, Seferovic P, Filippatos G, Coats A, Suter T, Von Haehling S, Ciardiello F, de Boer RA, Lyon AR, Tocchetti CG; Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology.

Eur J Heart Fail. 2018 May;20(5):879-887. doi: 10.1002/ejhf.1165. Epub 2018 Feb 21. Review.

46.

Heart Failure Stimulates Tumor Growth by Circulating Factors.

Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, Haubner BJ, Nagengast WB, Lyon AR, van der Vegt B, van Veldhuisen DJ, Westenbrink BD, van der Meer P, Silljé HHW, de Boer RA.

Circulation. 2018 Aug 14;138(7):678-691. doi: 10.1161/CIRCULATIONAHA.117.030816.

47.

The impact of inter-organizational alignment (IOA) on implementation outcomes: evaluating unique and shared organizational influences in education sector mental health.

Lyon AR, Whitaker K, Locke J, Cook CR, King KM, Duong M, Davis C, Weist MD, Ehrhart MG, Aarons GA.

Implement Sci. 2018 Feb 7;13(1):24. doi: 10.1186/s13012-018-0721-1.

48.

Assessing organizational implementation context in the education sector: confirmatory factor analysis of measures of implementation leadership, climate, and citizenship.

Lyon AR, Cook CR, Brown EC, Locke J, Davis C, Ehrhart M, Aarons GA.

Implement Sci. 2018 Jan 8;13(1):5. doi: 10.1186/s13012-017-0705-6.

49.

Enhanced "Train and Hope" for Scalable, Cost-Effective Professional Development in Youth Suicide Prevention.

Adrian M, Lyon AR, Nicodimos S, Pullmann MD, McCauley E.

Crisis. 2018 Jul;39(4):235-246. doi: 10.1027/0227-5910/a000489. Epub 2017 Nov 29.

PMID:
29183240
50.

A content analysis of dissemination and implementation science resource initiatives: what types of resources do they offer to advance the field?

Darnell D, Dorsey CN, Melvin A, Chi J, Lyon AR, Lewis CC.

Implement Sci. 2017 Nov 21;12(1):137. doi: 10.1186/s13012-017-0673-x.

Supplemental Content

Support Center